Should You Buy Vivos Therapeutics Inc (VVOS) Stock Monday Morning?

Monday, April 01, 2024 06:47 AM | InvestorsObserver Analysts

Mentioned in this article

Vivos Therapeutics Inc (VVOS) has fallen Monday morning, with the stock decreasing -15.32% in pre-market trading to 4.09. VVOS's short-term technical score of 27 indicates that the stock has traded less bullishly over the last month than 73% of stocks on the market. In the Medical Devices industry, which ranks 122 out of 146 industries, Vivos Therapeutics Inc ranks higher than 47% of stocks. Vivos Therapeutics Inc has fallen 12.02% over the past month, closing at $5.30 on March 4. During this period of time, the stock fell as low as $4.26 and as high as $5.71.

VVOS has an Overall Score of 12. Find out what this means to you and get the rest of the rankings on VVOS!
See Full VVOS Report
Vivos Therapeutics Inc has a Long-Term Technical rank of 10. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 90% of the market scoring higher. In the Medical Devices industry which is number 115 by this metric, VVOS ranks better than 115% of stocks.

Important Dates for Investors in VVOS:

-Vivos Therapeutics Inc is set to release earnings on 2024-04-04. Over the last 12 months, the company has reported EPS of $-13.19. -We do not have a set dividend date for Vivos Therapeutics Inc at this time. Click Here To Get The Full Report on Vivos Therapeutics Inc (VVOS)

Share this article:

Related Articles